CHICAGO, June 13 /PRNewswire/ -- The Emergency Nurses Association (ENA) today announced that PDL BioPharma has been named a strategic partner for 2007. As a strategic partner, PDL BioPharma will be the exclusive sponsor for the ENA State Leaders December Orientation and the Emergency Nurses Week, October 7-13, 2007. "We are very pleased to announce this partnership with PDL BioPharma," said Donna Mason, RN, MS, CEN, ENA President. "By partnering with ENA, PDL BioPharma gets a unique opportunity to show their support of the life saving work of emergency nurses across the county." Through this partnership, PDL BioPharma will help finance ongoing educational and professional networking activities, as well as events honoring nurses during emergency nurses week. "As a company committed to discovering, developing and marketing innovative therapies that will positively impact patients' lives, PDL BioPharma has great respect for emergency nurses' commitment to patients, which is exemplified by the extraordinary work they do in emergency departments everyday," said Jaisim Shah, senior vice president, marketing and business affairs, PDL BioPharma Inc. "Like our treatments for short-term hypertension treatment and acute myocardial infarction, these healthcare professionals are saving lives everyday. Through this partnership, we hope to raise the visibility of emergency nurses while showing our appreciation for everything that they do." In the United States and Canada, PDL BioPharma markets several commercial biopharmaceutical products for the hospital setting -- Cardene(R) I.V. (http://www.pdlbiopharma.com/index.cfm?navid=32) for the short-term treatment of hypertension, Retavase(R) (http://www.pdlbiopharma.com/index.cfm?navid=35) for acute myocardial infarction and IV Busulfex(R) (http://www.pdlbiopharma.com/index.cfm?navid=37) (Black Box Warning) for conditioning prior to a bone marrow transplant in association with chronic myelogenous leukemia. In addition to its marketed products, PDL has a novel antibody-focused proprietary pipeline, with a therapeutic focus in inflammation and autoimmune diseases, oncology, and cardiovascular disorders. The company's pioneering antibody humanization technology has also enabled nine products to be marketed in the United States. About the Emergency Nurses Association The Emergency Nurses Association (ENA) is the only professional nursing association dedicated to defining the future of emergency nursing and emergency care through advocacy, expertise, innovation, and leadership. Founded in 1970, ENA serves as the voice of more than 32,000 members and their patients through research, publications, professional development, injury prevention, and patient education. Additional information is available at ENA's Web site, at http://www.ena.org.
SOURCE Emergency Nurses Association